Not applicableStudy completedNCT00596388What this trial is testingUsage of the Home Macular Perimeter (HMP)Who this might be right forAge Related Macular Degeneration Notal Vision Ltd. 20
Large-scale testing (Phase 3)Study completedNCT02307682What this trial is testingEfficacy and Safety of RTH258 Versus Aflibercept - Study 1Who this might be right forNeovascular Age-Related Macular DegenerationChoroidal Neovascularization Alcon Research 1,775
Testing effectiveness (Phase 2)Study completedNCT00570193What this trial is testingPhotodynamic and Pharmacologic Treatment of CNVWho this might be right forChoroidal NeovascularizationMacular Degeneration Mid-Atlantic Retina Consultations, Inc. 41
Post-approval studies (Phase 4)Study completedNCT01006538What this trial is testingMacular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)Who this might be right forMacular Degeneration King's College Hospital NHS Trust 363
Large-scale testing (Phase 3)Study completedNCT00436553What this trial is testingEfficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal NeovascularizationWho this might be right forMacular DegenerationChoroidal Neovascularization Novartis 321
Not applicableStudy completedNCT00358345What this trial is testingPreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal NeovascularizationWho this might be right forAge Related Macular Degeneration Notal Vision Ltd. 347
Post-approval studies (Phase 4)Study completedNCT07090044What this trial is testingComparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour PeriodWho this might be right forVein OcclusionMacular Degeneration Choroidal NeovascularizationMacular Edema+1 more Retina Research Institute, LLC 77
Not applicableUnknownNCT02988895What this trial is testingEpiscleral Brachytherapy for the Treatment of Wet AMDWho this might be right forMacular Degeneration, Choroidal Neovascularization Salutaris Medical Devices, Inc. 11
Early research (Phase 1)Study completedNCT01051700What this trial is testingA Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansWho this might be right forMacular Degeneration GlaxoSmithKline 72
Testing effectiveness (Phase 2)Study completedNCT03038880What this trial is testingStudy to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular DegenerationWho this might be right forNeovascularization, ChoroidalMacular Degeneration, Age-Related Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079What this trial is testingA Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMDWho this might be right forNeovascular Age-Related Macular Degeneration Graybug Vision 56
Large-scale testing (Phase 3)Study completedNCT00429962What this trial is testingStudy Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVWho this might be right forChoroidal NeovascularizationAge-Related Macular Degeneration University Hospital, Basel, Switzerland 40
Not applicableStudy completedNCT01880788What this trial is testingGenetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDWho this might be right forAge Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy Sequenom, Inc. 152
Not applicableStudy completedNCT00656903What this trial is testingHigh Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationWho this might be right forMacular Degeneration National Eye Institute (NEI) 75
Testing effectiveness (Phase 2)Study completedNCT00363714What this trial is testingA Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forAge-Related Macular DegenerationChoroidal Neovascularization Allergan 26
Testing effectiveness (Phase 2)Ended earlyNCT00509548What this trial is testingOpen-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMDWho this might be right forMacular DegenerationChoroidal Neovascularization TargeGen 7
Not applicableStudy completedNCT05677685What this trial is testingVISUPRIME® Eye DropsWho this might be right forMacular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more VISUfarma SpA 78
Large-scale testing (Phase 3)Study completedNCT04597632What this trial is testingAn Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) StudyWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 248
Not applicableStudy completedNCT01080898What this trial is testingEvaluation of Optical Coherence Tomography.Who this might be right forAge-Related Macular DegenerationChoroidal Vessels; Anastomosis Assistance Publique - Hôpitaux de Paris 151
Post-approval studies (Phase 4)Study completedNCT01972789What this trial is testingComparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)Who this might be right forSubfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD Novartis Pharmaceuticals 349